Literature DB >> 11279631

Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.

S Hirawat1, S M Lichtman, S L Allen.   

Abstract

Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11279631     DOI： 10.1002/1096-8652(200103)66:3<224::aid-ajh1049>3.0.co;2-e

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  3 in total

Review 1.  Paravalvular Leaks-From Diagnosis to Management.

Authors:  Samuel Bernard; Evin Yucel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

2.  Severe haemolytic anaemia after valvuloplasty and annuloplasty.

Authors:  S Al Zeer; A Dalbeni; L Pozzani; A Lechi; P Delva
Journal:  BMJ Case Rep       Date:  2010-11-09

Review 3.  Cardiac prostheses-related hemolytic anemia.

Authors:  Mohamad Alkhouli; Ali Farooq; Ronald S Go; Sudarshan Balla; Chalak Berzingi
Journal:  Clin Cardiol       Date:  2019-05-06       Impact factor: 2.882
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.